EUVIMEDEUVIMED entdecken
Video/AudioOpen Access · CC BY 4.0

Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature

Mattia Domenichini, Michela Corsini, Cosetta Ravelli, Anastasia Ricci, Elisa Moreschi, Elisabetta Grillo, Camilla Maggi, Gianluca Baldanzi, Sonia Chiodini, Diana Eveline Sanchez-Amador, Julia Kraxner, Michael G Monaghan und 3 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218848 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Cancer Letters, 2026. Verfasst von Mattia Domenichini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Via Branze 39, Brescia, Italy; Mechanobiology Research Center …. Hauptthemen laut MEDLINE: Extracellular Matrix, Endothelium, Vascular, Vascular Endothelial Growth Factor Receptor-2, Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC Foundation for Cancer Research, Cariplo Foundation, Università degli Studi di Brescia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid tumors are highly dynamic environments, in which endothelial cells (ECs) interface with blood, cancer cells, and the extracellular matrix (ECM), thereby regulating tumor behavior and metastatic dissemination. We recently showed that aberrant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) activation promotes tumor progression through ECM remodeling. Here we investigated whether VEGFR2-driven ECM remodeling affects EC behavior and vessel stability. Using decellularized ECM from Sk-Mel-31 melanoma cells expressing either VEGFR2WT or the aberrant VEGFR2R1032Q mutant, we found that VEGFR2R1032Q reshapes ECM composition, including core matrisome components, ECM-modifying enzymes, and vascular-associated proteins. ECs seeded on VEGFR2R1032Q-derived ECM displayed altered adhesion dynamics, characterized by focal adhesion remodeling, increased haptotaxis, and impaired morphogenic capacity. This remodeled ECM also induced cytoskeletal reorganization and, disruption of VE-cadherin junctions via RhoA activation. Consistently, VEGFR2R1032Q-derived tumors exhibited more immature vessels with discontinuous junctions and the expression of mesenchymal markers. Under laminar flow, ECs exposed to VEGFR2R1032Q-ECM showed a delayed calcium dynamic, altered YAP localization, defective polarization, actin alignment and impaired shear-stress adaptation. Overall, these findings identify VEGFR2-driven ECM remodeling as a non-cell-autonomous mechanism that destabilizes tumor vasculature by impairing endothelial adhesion, mechanosensing, and junctional integrity, highlighting tumor/ECM/endothelium crosstalk as a potential therapeutic vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular MatrixEndothelium, VascularVascular Endothelial Growth Factor Receptor-2NeoplasmsEndothelial CellsHumansCell Line, TumorTumor MicroenvironmentMechanotransduction, Cellular

Stichwörter der Autor:innen

Cell-cell junctionEndothelial-to-mesenchymal transitionExtracellular matrixFocal adhesionMechanosensingTumoral vasculature

Substanzen

KDR protein, humanVascular Endothelial Growth Factor Receptor-2

Autor:innen und Institutionen

  • Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Via Branze 39, Brescia, Italy; Mechanobiology Research Center at UNIBS, Università degli Studi di Brescia, Italy.
  • Integrative Vascular Biology, Max Delbrück Center (MDC), Robert-Rössle-Straße 10, Berlin, Germany.
  • Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Via Branze 39, Brescia, Italy.
  • Center for Translational Research on Allergic and Autoimmune Diseases, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
  • Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Via Branze 39, Brescia, Italy; Discipline of Mechanical, Manufacturing and Biomedical Engineering, School of Engineering, Trinity Co…
  • Discipline of Mechanical, Manufacturing and Biomedical Engineering, School of Engineering, Trinity College Dublin, Dublin 2, Ireland.

Förderung

  • AIRC Foundation for Cancer Research
  • Cariplo Foundation
  • Università degli Studi di Brescia

Zitieren

APA

Domenichini, M., Corsini, M., Ravelli, C., Ricci, A., Moreschi, E., Grillo, E., Maggi, C., Baldanzi, G., Chiodini, S., Sanchez-Amador, D. E., Kraxner, J., Monaghan, M. G., Gerhardt, H., Menotta, M., & Mitola, S. (2026). Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218848

Vancouver

Domenichini M, Corsini M, Ravelli C, Ricci A, Moreschi E, Grillo E, et al. Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218848

BibTeX
@article{Domenichini2026,
  author = {Domenichini, Mattia and Corsini, Michela and Ravelli, Cosetta and Ricci, Anastasia and Moreschi, Elisa and Grillo, Elisabetta and Maggi, Camilla and Baldanzi, Gianluca and Chiodini, Sonia and Sanchez-Amador, Diana Eveline and Kraxner, Julia and Monaghan, Michael G and Gerhardt, Holger and Menotta, Michele and Mitola, Stefania},
  title = {Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218848}
}
Kostenlos starten →